These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery. Evensen L; Micklem DR; Link W; Lorens JB Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964 [TBL] [Abstract][Full Text] [Related]
6. Real-time visualization and characterization of tumor angiogenesis and vascular response to anticancer therapies. Xing HR; Zhang Q Methods Mol Biol; 2012; 872():115-27. PubMed ID: 22700407 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Laschke MW; Menger MD Hum Reprod Update; 2007; 13(4):331-42. PubMed ID: 17347159 [TBL] [Abstract][Full Text] [Related]
8. Review of the ocular angiogenesis animal models. Montezuma SR; Vavvas D; Miller JW Semin Ophthalmol; 2009; 24(2):52-61. PubMed ID: 19373687 [TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
10. Corneal assay for angiogenesis. Ziche M Methods Mol Med; 2001; 46():131-42. PubMed ID: 21340917 [TBL] [Abstract][Full Text] [Related]
11. Tumour angiogenesis: a novel therapeutic target in patients with malignant disease. O'Byrne KJ; Steward WP Expert Opin Emerg Drugs; 2001 Apr; 6(1):155-74. PubMed ID: 15989502 [TBL] [Abstract][Full Text] [Related]
12. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
13. In vivo models of angiogenesis. Norrby K J Cell Mol Med; 2006; 10(3):588-612. PubMed ID: 16989723 [TBL] [Abstract][Full Text] [Related]
14. A quantitative angiogenesis model for efficacy testing of chemopreventive agents. Sharma S; Ghoddoussi M; Gao P; Kelloff GJ; Steele VE; Kopelovich L Anticancer Res; 2001; 21(6A):3829-37. PubMed ID: 11911254 [TBL] [Abstract][Full Text] [Related]
15. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Hamsa TP; Kuttan G Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484 [TBL] [Abstract][Full Text] [Related]
18. Assessment methods for angiogenesis and current approaches for its quantification. AlMalki WH; Shahid I; Mehdi AY; Hafeez MH Indian J Pharmacol; 2014; 46(3):251-6. PubMed ID: 24987169 [TBL] [Abstract][Full Text] [Related]
19. Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing. Sanz L; Pascual M; Muñoz A; González MA; Salvador CH; Alvarez-Vallina L Microvasc Res; 2002 May; 63(3):335-9. PubMed ID: 11969310 [TBL] [Abstract][Full Text] [Related]
20. [Experimental approaches to study in vivo angiogenesis]. Kilarski W; Bikfalvi A Bull Cancer; 2007 Jul; 94 Spec No():S166-9. PubMed ID: 17846001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]